Hectorol: profile and news
Genzyme Reports Financial Results for Fourth Quarter of 2005 and ... Feb 15, 2006
...acquired from Avigen Inc., expiring Clolar(R) inventory acquired from ILEX Oncology Inc., and the turnover of the stepped-up value of Hectorol(R) inventory ... - MSN Money
Genzyme Reports Financial Results for Fourth Quarter of 2005 and ... Feb 15, 2006
...from Avigen Inc., expiring Clolar® inventory acquired from ILEX Oncology Inc., and the turnover of the stepped-up value of Hectorol® inventory acquired from ... - WebWire (press release),
Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue Jan 9, 2006
Both Renagel and Genzyme's Hectorol(R) (doxercalciferol)are positioned favorably on most of the Part D prescription drug plans now available to Medicare ... - MSN Money
Genzyme Calls for Research Proposals for Renal Innovations Progra ... Nov 15, 2005
For more information on the 2006 program and application details, please visit www.Renagel.com, www.Hectorol.com or send an email to grip@genzyme.com. ... - PharmaLive.com (press release),
FDA Safety Labeling Changes: Hectorol, Mevacor, Pulmicort Respules Sep 28, 2005
On June 22, the FDA approved safety labeling revisions for doxercalciferol injection (Hectorol, made by Bone Care International) to advise of treatment ... - Medscape (subscription)
R&D Business Sep 13, 2005
One key component in the acquisition is Bone Care’s Hectorol, a vitamin D2 pro-hormone product used to treat secondary hyperparathyroidism in patients on ... - R&D Directions (subscription),
Bone Care proves state can bring a brainchild to market Sep 3, 2005
In 1999, the drug - which Mazess had named Hectorol, after DeLuca - was approved for use in capsule form. ... They found another contractor to make Hectorol. ... - Milwaukee Journal Sentinel,
R&D Business Aug 4, 2005
One key component in the acquisition is Bone Care’s Hectorol, a vitamin D2 pro-hormone product used to treat secondary hyperparathyroidism in patients on ... - R&D Directions (subscription)
Genzyme Reports Second-Quarter GAAP EPS of $0.46, Non-GAAP EPS of ... Jul 14, 2005
Genzyme expanded its Renal business on July 1 with its acquisition of Bone Care International, a transaction that added Hectorol® (doxercalciferol) to the ... - Yahoo News (press release)
Professor is UW money tree Jul 16, 2005
DeLuca is an internationally respected expert on vitamin D, and his research is the basis for at least eight drugs - including Hectorol, his namesake - with ... - Wisconsin State Journal
UPDATE 2-Genzyme 2nd-quarter profit jumps 58 percent Jul 14, 2005
Genzyme said Bone Care's drug Hectorol is expected to generate about $45 million to $50 million in revenue in the second half of 2005. ... - Reuters
Genzyme Beats Estimates; Revenues Jump 22 Percent Jul 14, 2005
International Inc. for $600 million, which added Hectorol, a complementary product to Renagel, to Genzyme's product list. That transaction ... - BioWorld Online (subscription)
Business briefs Jul 15, 2005
Genzyme agreed to buy Bone Care, its seventh acquisition in the past two years, to gain kidney disease products including Hectorol, a vitamin D2 hormone ... - Worcester Telegram (subscription)
